Oxytetracycline dihydrate CAS:6153-64-6

Oxytetracycline dihydrate shares similar indications and uses with oxytetracycline. In human medicine, it is employed for the treatment of respiratory tract infections such as pneumonia and bronchitis, as well as skin and soft tissue infections including acne, rosacea, and infected wounds. Its broad spectrum of activity makes it effective against a variety of bacterial pathogens commonly encountered in clinical practice. In veterinary medicine, oxytetracycline dihydrate is widely utilized in the management of bacterial infections in livestock and poultry. It is commonly administered orally, intramuscularly, or intravenously to treat and prevent respiratory infections, enteritis, mastitis, and other bacterial diseases affecting farm animals. Oxytetracycline dihydrate plays a crucial role in maintaining animal health and productivity in agriculture. Topical formulations of oxytetracycline dihydrate are also available for veterinary use in the treatment of localized infections, including wounds, abscesses, and dermatological conditions such as foot rot in cattle and sheep. These formulations provide targeted antimicrobial therapy while minimizing systemic exposure and potential adverse effects. Adverse effects associated with oxytetracycline dihydrate therapy are similar to those of oxytetracycline, including gastrointestinal disturbances, photosensitivity reactions, and rare but serious complications such as hepatotoxicity and renal dysfunction. Proper medication administration, monitoring for adverse effects, and completion of the full treatment course are essential to ensure optimal outcomes and minimize the risk of antibiotic resistance. Collaboration between healthcare professionals and veterinarians is crucial for the appropriate use of oxytetracycline dihydrate in both human and veterinary medicine, promoting responsible antimicrobial stewardship and safeguarding public health.